Publications by authors named "Heiko Ullmann"

Claim this Profile
S
Synthesis and structure-activity relationships of suramin-derived P2Y11 receptor antagonists with nanomolar potency.
Heiko Ullmann, Sabine Meis, Darunee Hongwiset, Claudia Marzian, Michael Wiese

J Med Chem· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use-dependent inhibition of the skeletal muscle ryanodine receptor by the suramin analogue NF676.
Ilse Wolner, Matthias U Kassack, Heiko Ullmann, Anton Karel, Martin Hohenegger

Br J Pharmacol· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of platelet functions and thrombosis through selective or nonselective inhibition of the platelet P2 receptors with increasing doses of NF449 [4,4',4'',4'''-(carbonylbis(imino-5,1,3-benzenetriylbis-(carbonylimino)))tetrakis-benzene-1,3-disulfonic acid octasodium salt].
Béatrice Hechler, Stéphanie Magnenat, Maddalena L Zighetti, Matthias U Kassack, Heiko Ullmann

J Pharmacol Exp Ther· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The novel suramin analogue NF864 selectively blocks P2X1 receptors in human platelets with potency in the low nanomolar range.
Susanne Horner, Kirsten Menke, Caren Hildebrandt, Matthias U Kassack, Peter Nickel, Heiko Ullmann

Naunyn Schmiedebergs Arch Pharmacol· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Profiling at recombinant homomeric and heteromeric rat P2X receptors identifies the suramin analogue NF449 as a highly potent P2X1 receptor antagonist.
Jürgen Rettinger, Kirsten Braun, Henrike Hochmann, Matthias U Kassack, Heiko Ullmann

Neuropharmacology· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-activity relationships of analogues of NF449 confirm NF449 as the most potent and selective known P2X1 receptor antagonist.
Matthias U Kassack, Kirsten Braun, Matthias Ganso, Heiko Ullmann, Peter Nickel

Eur J Med Chem· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-activity relationships of suramin and pyridoxal-5'-phosphate derivatives as P2 receptor antagonists.
Günter Lambrecht, Kirsten Braun, MiSusannechelle Damer, Matthias Ganso, Caren Hildebrandt, Heiko Ullmann

Curr Pharm Des· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis